Carter Kenneth C

Avg. Two Year Performance

(45%) Avg. Purchase Return
(21%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(11%)(2%)8%(< 1%)(45%)
Purchase Success Rate0 of 21 of 21 of 21 of 20 of 2
Average Sale Return2%21%52%88%0%
Sale Success Rate1 of 11 of 11 of 11 of 10 of 1
Drugs » Diagnostic Substances

President and CEO, Director:

Holdings: 27.63K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Executive Chairman, Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--